liver-cancer

Documents about liver-cancer

• Implementing Online Patient-Provider Communication Into Clinical Practice#160288ClinicalTrials.gov
• Improving the Use of Immunotherapy to Treat Liver Cancer#471451ClinicalTrials.gov
• Study of Pembrolizumab and Radiotherapy in Liver Cancer#914109ClinicalTrials.gov
• Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy#967194ClinicalTrials.gov
• Clinical Need and Research Investment for Liver Cancer in Australia#1005538The University of Melbourne Library Digital Repository
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract#813325ClinicalTrials.gov
• Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden#855517ClinicalTrials.gov
• A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases#885714ClinicalTrials.gov
• Accumulation of Lipid Droplets as an Underlying Cause of the Progression of Fatty Liver Disease to Liver Cancer#993261ClinicalTrials.gov
• 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis#1044556ClinicalTrials.gov
• Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma#853776ClinicalTrials.gov
• Stereotactic Magnetic Resonance Guided Radiation Therapy#879808ClinicalTrials.gov
• Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer#804837ClinicalTrials.gov
• The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy#892977ClinicalTrials.gov
• Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy#840859ClinicalTrials.gov
• A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis#911838ClinicalTrials.gov
• Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients#287556ClinicalTrials.gov
• Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment#863095ClinicalTrials.gov
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking#1044788ClinicalTrials.gov
• Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy#806354ClinicalTrials.gov
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors#981467ClinicalTrials.gov
• Treatment for Bile Duct Cancer in the Liver#919065ClinicalTrials.gov
• A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors#831021ClinicalTrials.gov
• Volatiles in Breath and Headspace Analysis - Diagnostic Markers#882366ClinicalTrials.gov
• Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases#268014ClinicalTrials.gov
• Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy#967783ClinicalTrials.gov
• Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC#981014ClinicalTrials.gov
• Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)#383564ClinicalTrials.gov
• Prognostic Factors for Patients Under 45 Undergoing Surgery for Colorectal Liver Metastases: A SEER Population-Based Study#409579ODU Digital Commons
• Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver#1007012ClinicalTrials.gov
• Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases#1038913HAL (France)
• Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery#856416ClinicalTrials.gov
• A Single-Arm, Phase II Study of Retlirafusp Alfa in Combination With XELOX and Bevacizumab for the First-Line Treatment of Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)#887407ClinicalTrials.gov
• Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2#861696ClinicalTrials.gov
• Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy#18609ClinicalTrials.gov
• New prognostic and predictive scoring systems for colorectal cancer liver metastases.#67481NCBI PubMed Central
• The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers.#345238NCBI PubMed Central
• Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)#892110ClinicalTrials.gov
• Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival.#988425NCBI PubMed Central
• The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis#1044585ClinicalTrials.gov
• Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer#810750ClinicalTrials.gov
• Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver#1044327ClinicalTrials.gov
• Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma#340172IRIS
• A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients#444886ClinicalTrials.gov
• Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure#836078ClinicalTrials.gov
• Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer#896923ClinicalTrials.gov
• A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy#1045436ClinicalTrials.gov
• Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers#901658ClinicalTrials.gov
• Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer#870637ClinicalTrials.gov
• Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies#875062ClinicalTrials.gov